Ask AI
ProCE Banner Activity

Increasing Complexity in MCL Treatment Decisions and the Value of Interactive Tools

Clinical Thought

In this commentary learn how interactive treatment decision–support tools can positively affect evidence-based therapeutic choices for patients with mantle cell lymphoma (MCL) in an increasingly complex therapeutic landscape, and give Clinical Care Option’s latest expert-led MCL tool a test run at the provided link.

Released: July 21, 2025

Expiration: January 20, 2026

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Disclosure

Primary Author

Julie M. Vose, MD, MBA: consultant/advisor/speaker: AbbVie, AstraZeneca, GenMab, Lilly.